The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Incidence and Late Prognosis of Cushing’s Syndrome: A Population-Based Study1
Abstract
The main purpose was to assess the incidence and late outcome of Cushing's syndrome, particularly in Cushing's disease. Information for all patients diagnosed with Cushing's syndrome during an 11-yr period in Denmark was retrieved. The incidence was 1.2-1.7/million.yr (Cushing's disease), 0.6/million.yr (adrenal adenoma) and 0.2/million.yr (adrenal carcinoma). Other types of Cushing's syndrome were rare. In 139 patients with nonmalignant disease, 11.1% had died during follow-up (median, 8.1 yr; range, 3.1-14.0), yielding a standard mortality ratio (SMR) of 3.68 [95% confidence interval (CI), 2.34-5.33]. The SMR was partly attributable to an increased mortality within the first year after diagnosis. Eight patients died before treatment could be undertaken. The prognosis in patients with malignant disease was very poor. Patients in whom more than 5 yr had elapsed since initial surgery were studied separately, including a questionnaire on their perceived quality of health. In 45 patients with Cushing's disease who had been cured through transsphenoidal neurosurgery, only 1 had died (SMR, 0.31; CI, 0.01-1.72) compared with 6 of 20 patients with persistent hypercortisolism after initial neurosurgery (SMR, 5.06; CI, 1.86-11.0). In patients with adrenal adenoma, SMR was 3.95 (CI, 0.81-11.5). The perceived quality of health was significantly impaired only in patients with Cushing's disease and appeared independent of disease control or presence of hypopituitarism. It is concluded that 1) Cushing's syndrome is rare and is associated with increased mortality, in patients with no concurrent malignancy also; 2) the excess mortality was mainly observed during the first year of disease; and 3) the impaired quality of health in long-term survivors of Cushing's disease is not fully explained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SF-36 health survey: Manual and interpretation guide
Ware, J. (2003) · Medical Entomology and Zoology · Cited by 11,424
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Morbidity and mortality in Cushing's disease: an epidemiological approach.
Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622
Colao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2664 · Cited by 450
The Danish registers of causes of death.
Juel, K., & Helweg‐Larsen, K. (1999) · PubMed · Cited by 411
Bochicchio, D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3114 · Cited by 344
Risk factors and long-term outcome in pituitary-dependent Cushing's disease
Sonino, N. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.7.2647 · Cited by 265
Long-Term Mortality after Transsphenoidal Surgery for Cushing Disease
Swearingen, B., Biller, B. M. K., Barker, F. G., Katznelson, L., Grinspoon, S., Klibanski, A., & Zervas, N. T. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-10-199905180-00015 · Cited by 231
Blevins, L. S., Christy, J. H., Khajavi, M., & Tindall, G. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4525 · Cited by 167
Guilhaume, B., BERTAGNA, X. Y., THOMSEN, M., Bricaire, C., Vila‐Porcile, É., Olivier, L., Racadot, J., Derome, P., Laudat, M. H., Girard, F., et al. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-5-1056 · Cited by 150
Long-Term Outcome in Children and Adolescents after Transsphenoidal Surgery for Cushing’s Disease1
Devoe, D. J., Miller, W. L., Conte, F. A., Kaplan, S. L., Grumbach, M. M., Rosenthal, S. M., Wilson, C. B., & Gitelman, S. E. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4290 · Cited by 147
Rose, M. S., Koshman, M. L., Spreng, S., & Sheldon, R. S. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00014-1 · Cited by 123
TRANSSPHENOIDAL SURGERY FOR CUSHING'S DISEASE: DOES WHAT IS REMOVED DETERMINE THE ENDOCRINE OUTCOME?
Burke, C. W., Adams, C. B. T., Esiri, M. M., Morris, C. S., & Bevan, J. S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb03890.x · Cited by 120
Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood
Leinung, M. C., Kane, L. A., Scheithauer, B. W., Carpenter, P. C., Laws, E. R., & Zimmerman, D. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.8.7629245 · Cited by 118
The survival and well‐being of patients treated for Cushing’s syndrome
Pikkarainen, L., Sane, T., & Reunanen, A. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00483.x · Cited by 118
Long term results of transsphenoidal adenomectomy in patients with Cushing??s disease
Nakane, T., Kuwayama, A., Watanabe, M., Takahashi, T., Kato, T., Ichihara, K., & Kageyama, N. (1987) · Neurosurgery · doi:10.1097/00006123-198708000-00015 · Cited by 117
Imai, T., Funahashi, H., Tanaka, Y., Tobinaga, J., Wada, M., Morita‐Matsuyama, T., Ohiso, Y., & Takagi, H. (1996) · World Journal of Surgery · doi:10.1007/s002689900119 · Cited by 59
Survival and causes of death after adrenalectomy for Cushing's disease.
Rb, W. (1985) · PubMed · Cited by 50
Long-term results of treatment of Cushing's disease by adrenalectomy.
Grabner, P., Hauer‐Jensen, M., Jervell, J., & Flatmark, A. L. (1991) · PubMed · Cited by 50
Hjortrup, A., Kehlet, H., Lindholm, J., & Stentoft, P. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-3-668 · Cited by 40
Self-citationVälimäki, M. J., Pelkonen, R., Porkka, L., Sivula, A. H., & Kahri, A. I. (1984) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1984.tb00078.x · Cited by 36
CLEVELAND CLINIC EXPERIENCE WITH ADRENAL CUSHING'S SYNDROME
Daitch, J. A., Goldfarb, D. A., & Novick, A. C. (1997) · The Journal of Urology · doi:10.1016/s0022-5347(01)68151-5 · Cited by 32
Pituitary histology in Cushing's disease
Kruse, A., Klinken, L., Holck, S., & Lindholm, J. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02319.x · Cited by 27
Self-citationRoss, E. J., & Linch, D. C. (1985) · Postgraduate Medical Journal · doi:10.1136/pgmj.61.713.205 · Cited by 22
Cited by
Barlow, S. E., & and the Expert Committee (2007) · Pediatrics · doi:10.1542/peds.2007-2329c · Cited by 4,497
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718
“Because some patients with Cushing’s disease demonstrate suppressibility to dexamethasone, use of this diagnostic criterion J Clin Endocrinol Metab, May 2008, 93(5):1526–1540 jcem.”
BackgroundInfluentialLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline
Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1818 · Cited by 1,270
A 12-month phase 3 study of pasireotide in Cushing's disease
Colao, A., Petersenn, S., Newell-Price, J., Findling, J. W., Gu, F., Maldonado, M., Schoenherr, U., Dipl.-Biol., Mills, D., Salgado, L. R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105743 · Cited by 628
Metadata
- Authors
- Lindholm, J., Juul, S., Jørgensen, J. O. L., Astrup, J., Bjerre, P., Feldt-Rasmussen, U., Hagen, C., Jørgensen, J., Kosteljanetz, M., Kristensen, L. Ø., Laurberg, P., Schmidt, K., & Weeke, J.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-01
- Volume
- 86
- Issue
- 1
- Pages
- 117-123
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2117589135
- Cited by
- 619
- References
- 24
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.